-8.3% · 90d
$69.22
+0.99 (+1.45%)
After-Hours $69.22(+0.00)
News
(1)April 2026
PTCT shareholders vote on board structure and 2026 governance proposals
PTCTPTC THERAPEUTICS, INC.
# 📜 What This Document Is 🗓️ This is a Proxy Statement (DEF 14A), which is like a comprehensive instruction manual and invitation to an annual shareholder meeting. Instead of just reporting numbers, this document is designed to inform you—the shareholder—about how the company is run, who is leadin
Read summaryView on SEC EDGAR
Peers in Biotechnology
VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%